Ticker: LUCD

Snapshot - Lucid Diagnostics Inc. (NASDAQ: LUCD) Short take: Lucid is a commercial-stage diagnostics company pushing EsoGuard/EsoCheck to market. The business is showing clinical traction and reimbursement momentum but remains cash‑burning, loss-making and dependent on additional financing and pa...